Timothy Shaw - 15 Jul 2026 Form 4 Insider Report for MARIMED INC. (MRMD)

Reporting relationship: Chief Operating Officer
Issuer ticker: MRMD
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2026, 16:13:17 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Timothy Shaw

Key filing fact

Timothy Shaw filed Form 4 for MARIMED INC. (MRMD) on 17 Jul 2026.

Key facts

This page summarizes Timothy Shaw's Form 4 filing for MARIMED INC. (MRMD).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Jul 2026, 16:13.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001866577 Primary reporting owner

Shaw Timothy

Relationship: Chief Operating Officer
Address: C/O MARIMED INC., 10 OCEANA WAY, NORWOOD,
Signature: /s/ Timothy Shaw
Signature date: 15 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRMD transaction

Common stock

Options Exercise

Transaction value
Shares: +42,656
Change %: +0.45%
Price: $0.000000^*
Shares after: 9,426,904
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F1

MRMD transaction

Common stock

Tax liability

Transaction value
Shares: -14,781
Change %: -0.16%
Price: $0.0662^*
Shares after: 9,412,123
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F2

MRMD holding

Common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,000,000
Date: 15 Jul 2026
Ownership: By the Shaw Family Trust
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRMD transaction Derivative

Restricted Stock Units (RSU)

Options Exercise

Transaction value
Shares: -42,656
Change %: -25%
Price: $0.000000^*
Shares after: 127,969
Date: 15 Jul 2026
Ownership: Direct
Underlying class: Common Stock, par value $.001 per share
Underlying amount: 42,656
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

RSUs convert to shares of common stock on a one-for-one basis.

Footnote F2

Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

Footnote F3

The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.